Promoting cancer in global health and development agendas.

In 2020, an estimated 19.3 million people were newly diagnosed with cancer. It is expected that by 2030, this number will rise to 21.6 million. This alarming trend can be reversed with strong action at global and national level. 

UICC is the only organisation of its type globally, dedicated to uniting and working with the cancer community. It has a unique capability to unite voices from around the world. UICC’s pledge to its members is to ensure that they have the opportunity and the channels to have their voices heard on the global stage and that the latest updates in the global health space will be curated and shared with them. 

Cancer control advocacy

Cancer control advocacy is the strategic process of influencing governments, decision makers and other key stakeholders to develop the commitments, plans and policies, and allocate the resources needed to drive change.

UICC works across the policy cycle to help bring together the evidence base for effective cancer control, develop tools to support national advocacy and share examples of successful policy change.

Knowledge, Advocacy and Policy cycle

Knowledge, Advocacy and Policy cycle.png

Click image to view larger

Knowledge – bringing together the evidence-base for effective cancer control.

Advocacy – influencing decision makers and other stakeholders to change policies to improve cancer outcomes.

Policy – Developing and implementing policies and programmes to improve cancer and health outcomes.

Timeline icon

Our impact

The past decade has seen the creation of a global framework to drive improvements in the prevention, diagnosis, treatment and care for cancer patients and people living with other NCDs. UICC is proud to have been an active partner in this process. The interactive timeline provides a quick snapshot of the major ‘wins’ that global advocacy has been able to deliver, and you can explore these further using the global cancer commitments navigator.

Advocacy priorities

Looking ahead to 2030 and beyond, UICC has reflected on where it can leverage its expertise and platforms to better support members and the global health community in driving change. From this process, five areas have been identified where UICC can help build momentum for change.

Click on any of the advocacy priorities below (and the sub-topics related) to view more information.  

Improve comprehensive cancer planning
Make the case for investing in cancer control
Maintain the momentum behind cancer prevention
Increase access to diagnosis, treatment and care
Build partnerships to support global cancer control



Latest advocacy news & blog articles
Man smoking a cigarette
22 September 2021

The smokescreen of the tobacco industry's use of science

Tobacco industry claims that it is moving away from harmful smoke products and investing in health care are undermined by conflicts of interest and the manipulation of information and science.

A doctor helps a mother and her child at the hospital.
15 September 2021

Improving the chances of cure for childhood cancer in Brazil

Roberta Costa Marques, Executive Director of Instituto Desiderata in Brazil, speaks about the organisation's experience in mobilising networks to overcome regional differences in access to treatment.

Two medical practioners in personal protective equipment at a makeshift COVID-19 hospital in India.
13 September 2021

Cancer care in India during COVID-19: lessons learned and innovations

While tragically making international headlines in April 2021 with the emergence of Delta variant of COVID-19, cancer care suffered less in 2021 due to lessons learned from the first wave in 2020.

Elderly couple eating watermelon symbolising a healthier lifestyle through nutrition
8 September 2021

Preventing cancer through our lifestyle choices

Drawing on the learnings of the COVID-19 pandemic and the power of modifying behaviour to promote health, Swiss Re's Global Chief Medical Officer, John Schoonbee, discusses the role of lifestyle choices in preventing cancer.

Participants in the 3000-km Country to Country for Cancer ride in Europe, 3-20 September 2021
2 September 2021

Cycling nearly 3,000km through 7 countries to raise money for cancer

This 3-20 September, employees of Bristol Myers Squibb will cycle 3,000km across seven countries in the Country to Country for Cancer (C2C4C) in support of cancer research and European cancer organisations.

Staff at Esperantra, a patient assistance and advocacy organisation in Peru
26 August 2021

Cancer and COVID-19 in Peru: cancer advocacy success in the midst of a deadly pandemic

Cancer screenings and treatments have dropped dramatically in Peru due to COVID-19, which has strained an already fragile health system and exacted a heavy toll on cancer services. Yet UICC member Esperantra continues to advocate successfully for improved and more equitable access to cancer care.

Key advocacy initiatives

World Cancer Declaration Progress Report 2016


The 1000-strong UICC membership have worked collectively to create the World Cancer Declaration Progress Report 2016, providing a unique civil society perspective on national successes and major challenges that remain to realise the Declaration targets, with perspectives from 113 countries.

Global Cancer Commitments Navigator

Navigator image.png

The navigator highlights the links between international, time-bound commitments to build compelling arguments for national action on cancer.

Explore our work
Advocacy impact
Cancer planning
Investing in cancer control
Working together
Advocacy resources
The importance of the advocacy work

"We are proud to call ourselves one of the first partners of UICC. UICC called on our expertise in the area of cancer prevention for the global advocacy campaign. Together, UICC and its members have successfully placed cancer on the global stage, putting the cancer community in position for even greater success in the years to come.”

Dr Kate Allen, Director, Science and Communications

"Accurate and timely diagnosis is the first enemy of cancer, as it clips its potential from the outset and halts it from invading and conquering the whole body. Unfortunately, many cancer patients, especially in the developing world, do not have this safety net, and are completely exposed to cancer’s advances without any checks. We need a robust cancer resolution that encourages fast improvements in early detection and diagnosis through a clear and urgent health system response."

HRH Princess Dina Mired
Last update: 
Wednesday 10 February 2021